Header Logo

Connection

Rafael Tomoya Michita to Reverse Transcriptase Inhibitors

Back to Details
This is a "connection" page, showing publications Rafael Tomoya Michita has written about Reverse Transcriptase Inhibitors.
Rafael Tomoya Michita
Connection Strength
0.265
Reverse Transcriptase Inhibitors
  1. CYP2B6 516 G>T polymorphism and side effects of the central nervous system in HIV-positive individuals under Efavirenz treatment: Study of a sample from southern Brazil. An Acad Bras Cienc. 2017 May; 89(1 Suppl?0):497-504.
    View in: PubMed
    Score: 0.265
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.